This book chapter advances SDG 3 and 10 by exploring the gap within research literature in which the intersectional complexities of South Asian Muslims lie by examining the historical and geopolitical contexts of South Asian Muslim experiences in the United States. This chapter discusses the ways in which contemporary South Asian Muslim American experiences are further complicated when navigating additional marginalized identities such as gender and sexual orientation, age and generational influences, disability status, class, and national origin.
This book chapter advances SDG 3 and 10 reviewing the extent to which coronavirus lockdown and restrictions have affected the life of the people of Ghana
This book chapter advances SDG 3 and 10 by discussing the importance of social support and psychological flexibility to act as a buffer between the effects of COVID-19 on psychological distress and mental health.
In this 60-minute webinar, Terri M. Solomon and Dr. Marc McElhaney explain how to prepare for and handle a serious employee mental health crisis that prevents an employee from caring for themselves or puts an employee at risk of hurting themselves or others. The discussion supports SDG 3 (good health and well being).
The pharmacologic parameters that drive optimal HIV latency reversal in vivo are unknown and could be influenced by such factors as the HDACi binding kinetics, concentration of compound, and duration of exposure. This study evaluates how these parameters affect HIV latency reversal for a series of novel HDACis that differ in their enzymatic on and off rates. The comprehensive data set generated by automating the assays described here was used to establish a PK/PD model for HDACi-induced HIV latency reversal.
Main participants in a PPP—core strengths and key benefits in drug discovery/development. The figure provides an overview of the main participants in a PPP, highlights their core strengths, and lists important benefits across the various stages of the dru
Collaborative efforts between public and private entities such as academic institutions, governments, and pharmaceutical companies form an integral part of scientific research, and notable instances of such initiatives have been created within the life science community. Several examples of alliances exist with the broad goal of collaborating toward scientific advancement and improved public welfare. Such collaborations can be essential in catalyzing breaking areas of science within high-risk or global public health strategies that may have otherwise not progressed. A common term used to describe these alliances is public-private partnership (PPP). This review discusses different aspects of such partnerships in drug discovery/development and provides example applications as well as successful case studies. Specific areas that are covered include PPPs for sharing compounds at various phases of the drug discovery process—from compound collections for hit identification to sharing clinical candidates. Instances of PPPs to support better data integration and build better machine learning models are also discussed. The review also provides examples of PPPs that address the gap in knowledge or resources among involved parties and advance drug discovery, especially in disease areas with unfulfilled and/or social needs, like neurological disorders, cancer, and neglected and rare diseases.
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by elucidating nutrition as a fundamental domain of global health. It highlights the health of individuals and the stability of populations within the academic discipline of global health.
This chapter advances the UN SDG Goal 3: Good Health and Goal 10: Reduced Inequalities by bringing attention to the urgent need for high-quality mental health services and psychosocial support in crisis areas.
In this episode of the “World We Want” podcast series, RELX’s Global Head of Corporate Responsibility, Dr. Márcia Balisciano, talks to Tessy Antony de Nassau about leadership.
This chapter advances the UN SDG goals 3 and 5 by providing an overview of common fungal infections of the mammary gland, which have consequences for mothers and babies.

Pages